+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global DNA Repair Drugs Market by Drug Type (Alkylating Agents, Poly ADP Ribose Polymerase Inhibitors), Form (Capsules, Injectables, Tablets), Mechanism of Action, Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977983
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The DNA Repair Drugs Market grew from USD 8.58 billion in 2023 to USD 9.18 billion in 2024. It is expected to continue growing at a CAGR of 7.20%, reaching USD 13.97 billion by 2030.



DNA repair is a compilation of processes by which a cell identifies and repairs damage to the DNA molecules that encode its genome. These medications treat various cancers, aging-related conditions, and neurodegenerative diseases by enhancing the body's natural ability. Progress in genomic medicine, biotechnology, and diagnostic tools enable more targeted and efficient drug development processes. Additionally, the rising prevalence of cancer necessitates effective treatments, thereby enhancing the need for DNA repair drugs. However, developing DNA repair drugs can be resource-intensive and expensive, slowing the development process of drugs. Furthermore, developing more sophisticated DNA sequencing and analysis methods to identify repair deficits and customize drug therapies can pave the way for DNA repair drugs. Moreover, utilizing nanotechnology to enhance the delivery and effectiveness of DNA repair drugs has the potential to revolutionize treatment for rare diseases.

Regional Insights

In the Americas, majorly the United States and Canada represent rapid growth in DNA repair drugs due to infrastructure for drug development and delivery. Consumer needs in the Americas center on advanced treatment options and personalized medicine, reflecting a high awareness of genetic disorders and their impact. In European Union countries, stringent regulations and a strong framework for protecting clinical trial data promote innovation while ensuring patient safety. Consumers in the EU prefer therapies that are both effective and provide minimal side effects catered to the development of DNA repair drugs. The Africa and Middle East region presents a diverse picture where gulf countries such as the UAE and Saudi Arabia increasingly invest in healthcare infrastructure, including genetic research. Africa is making strides with initiatives to enhance healthcare capabilities, which could increase receptivity to advanced therapeutic options for genetic treatments. The APAC region is emerging as a developing region for DNA repair drugs due to significant investments in biotechnology and rapid advancements in genomic research, reflecting a strong governmental push towards revolutionizing global science.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the DNA Repair Drugs Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing incidences of chronic and genetic diseases across the world
  • Expanding clinical trials and research initiatives to develop DNA repair drugs
  • Government initiatives to promote access to treatments for complex diseases

Market Restraints

  • Formulation issues and complexities of DNA repair drugs

Market Opportunities

  • Ongoing innovations to improve the efficacy and safety of DNA repair drugs
  • Consumer preference for personalized and precision strategies to manage complex diseases

Market Challenges

  • Limitations associated with efficacy and safety concerns

Market Segmentation Analysis

  • Form: Significant adoption of injectables for quick delivery of medication
  • Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the DNA Repair Drugs Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the DNA Repair Drugs Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations

Merck KGaA has announced a collaboration with Jiangsu Hengrui Pharmaceuticals Co., Ltd., focusing on the development of DNA damage response (DDR) drugs. This deal granted Merck KGaA the rights to develop, manufacture, and market Jiangsu Hengrui Pharmaceuticals Co., Ltd.’s cancer drug candidate, HRS-1167, outside China.

Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs

F. Hoffmann-La Roche AG has secured a global license to advance KSQ-4279, a small molecule drug, started in 2024. KSQ-4279 is currently undergoing phase 1 trials targeting solid tumors and functions by inhibiting ubiquitin-specific peptidase 1 (USP1), a protein in DNA repair processes.F. Hoffmann-La Roche AG's financial commitment included an undisclosed upfront payment along with potential milestone and royalty disbursements, reinforcing the mutual dedication to DNA repair drug development.

FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations

Pfizer Inc.'s FDA approval marked an advancement in treating metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene mutations. The approved therapy combined TALZENNA (talazoparib), a poly ADP-ribose polymerase (PARP) inhibitor, with XTANDI (enzalutamide), showing an approach in a patient subset with historically poor outcomes. Based on the Phase 3 TALAPRO-2 trial findings, this combination demonstrated a 55% reduction in the risk of disease progression or death in mCRPC patients specifically identified with mutations such as BRCA1/2 and others.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the DNA Repair Drugs Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the DNA Repair Drugs Market, highlighting leading vendors and their innovative profiles. These include Artios Pharma, AstraZeneca PLC, Aurigene Discovery Technologies, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CanBas Co., Ltd., Clovis Oncology, Corden Pharma International GmbH, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline PLC, Hanson Wade Group, Johnson & Johnson Services, Inc., Merck KgaA, Novartis AG, Pfizer Inc., and Valerio Therapeutics.

Market Segmentation & Coverage

This research report categorizes the DNA Repair Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Type

  • Alkylating Agents
  • Poly ADP Ribose Polymerase Inhibitors

Form

  • Capsules
  • Injectables
  • Tablets

Mechanism of Action

  • Base Excision Repair Modulators
  • Double-strand Break Repair Modulators
  • Mismatch Repair Modulators
  • Single-strand Break Repair Modulators

Application

  • Neurological Diseases

Oncology

  • Breast Cancer
  • Ovarian Cancer
  • Prostate Cancer

Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of chronic and genetic diseases across the world
5.1.1.2. Expanding clinical trials and research initiatives to develop DNA repair drugs
5.1.1.3. Government initiatives to promote access to treatments for complex diseases
5.1.2. Restraints
5.1.2.1. Formulation issues and complexities of DNA repair drugs
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the efficacy and safety of DNA repair drugs
5.1.3.2. Consumer preference for personalized and precision strategies to manage complex diseases
5.1.4. Challenges
5.1.4.1. Limitations associated with efficacy and safety concerns
5.2. Market Segmentation Analysis
5.2.1. Form: Significant adoption of injectables for quick delivery of medication
5.2.2. Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. DNA Repair Drugs Market, by Drug Type
6.1. Introduction
6.2. Alkylating Agents
6.3. Poly ADP Ribose Polymerase Inhibitors
7. DNA Repair Drugs Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Injectables
7.4. Tablets
8. DNA Repair Drugs Market, by Mechanism of Action
8.1. Introduction
8.2. Base Excision Repair Modulators
8.3. Double-strand Break Repair Modulators
8.4. Mismatch Repair Modulators
8.5. Single-strand Break Repair Modulators
9. DNA Repair Drugs Market, by Application
9.1. Introduction
9.2. Neurological Diseases
9.3. Oncology
10. DNA Repair Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
11. Americas DNA Repair Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific DNA Repair Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa DNA Repair Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations
14.3.2. Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs
14.3.3. FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. DNA REPAIR DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DNA REPAIR DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DNA REPAIR DRUGS MARKET DYNAMICS
FIGURE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DNA REPAIR DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 89. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 90. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 91. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 92. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 93. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 94. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 95. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 98. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 99. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 100. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 101. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 102. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 103. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 104. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 105. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 106. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 107. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 110. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 111. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 112. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 154. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 155. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 156. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 157. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 158. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 159. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 162. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 163. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 166. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 167. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 168. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 169. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 170. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 171. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 174. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 175. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 178. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 190. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 191. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 192. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 193. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 194. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 195. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 198. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 199. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 200. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 201. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 202. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 203. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 204. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 205. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 206. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 214. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 215. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 216. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 217. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 218. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 226. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 227. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 228. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 229. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 230. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 238. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 239. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 240. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 241. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 250. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 251. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 252. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 253. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 254. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 262. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 263. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 264. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 265. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 266. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 267. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 270. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 271. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 274. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 275. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 276. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 277. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 278. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 299. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 300. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 301. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 302. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 303. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 304. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 305. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 308. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 309. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 312. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 313. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 314. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 315. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 316. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 317. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 320. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 321. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 322. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 323. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 324. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 325. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 326. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 327. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 328. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 329. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 332. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 333. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 334. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 335. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 336. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 337. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 338. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 339. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 340. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 341. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 344. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2024-2030 (USD MILLION)
TABLE 345. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 346. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 347. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 348. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 349. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 350. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 351. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 352. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 353. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)
TABLE 356. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2023 (USD MILLION)

Companies Mentioned

  • Artios Pharma
  • AstraZeneca PLC
  • Aurigene Discovery Technologies
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • CanBas Co., Ltd.
  • Clovis Oncology
  • Corden Pharma International GmbH
  • Eli Lilly and Company
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Hanson Wade Group
  • Johnson & Johnson Services, Inc.
  • Merck KgaA
  • Novartis AG
  • Pfizer Inc.
  • Valerio Therapeutics

Methodology

Loading
LOADING...

Table Information